1036724-61-4

Basic information

• Product Name: 1-BroMo-2-fluoro-4-isopropoxybenzene
• Synonyms: 1-BroMo-2-fluoro-4-isopropoxybenzene
• CAS NO: 1036724-61-4
• Molecular Formula: C₉H₁₀BrFO
• Molecular Weight: 233.0775032
• Mol File: 1036724-61-4.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-BroMo-2-fluoro-4-isopropoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BroMo-2-fluoro-4-isopropoxybenzene(1036724-61-4)
• EPA Substance Registry System: 1-BroMo-2-fluoro-4-isopropoxybenzene(1036724-61-4)

Safety Data

• Hazardous Substances Data: 1036724-61-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-Bromo-2-fluoro-4-isopropoxybenzene is used as a key intermediate in the synthesis of pharmaceutical compounds for its ability to contribute to the development of biologically active molecules. Its unique structure allows for the creation of new drugs with specific therapeutic properties.
Used in Agrochemicals:
In the agrochemical industry, 1-bromo-2-fluoro-4-isopropoxybenzene is used as a precursor in the production of various agrochemicals, potentially enhancing crop protection and management through the development of novel pesticides and herbicides.
Used in Materials Science:
1-Bromo-2-fluoro-4-isopropoxybenzene is utilized in materials science for the synthesis of new materials with specific properties, such as improved thermal stability or chemical resistance, which can be applied in various industrial applications.

Upstream product

• 348-57-2 2,4-difluorobromobenzene 
• 67-63-0 isopropyl alcohol 
• 121219-03-2 4-bromo-3-fluorophenol 
• 75-26-3 isopropyl bromide 

Downstream Products

• 1374584-24-3 (4-chlorophenyl)(2-fluoro-4-(propan-2-yloxy)phenyl)pyridin-3-yl methanol 

Relevant articles and documents

AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF A7-NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel aminobenzisoxazole compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of ot7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

Analogues of fenarimol are potent inhibitors of trypanosoma cruzi and are efficacious in a murine model of chagas disease

We report the discovery of nontoxic fungicide fenarimol (1) as an inhibitor of Trypanosoma cruzi (T. cruzi), the causative agent of Chagas disease, and the results of structure-activity investigations leading to potent analogues with low nM IC50s in a T. cruzi whole cell in vitro assay. Lead compounds suppressed blood parasitemia to virtually undetectable levels after once daily oral dosing in mouse models of T. cruzi infection. Compounds are chemically tractable, allowing rapid optimization of target biological activity and drug characteristics. Chemical and biological studies undertaken in the development of the fenarimol series toward the goal of delivering a new drug candidate for Chagas disease are reported.

NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention relates to new piperidine derivatives of the formula I to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

Regioselective SNAr reactions of substituted difluorobenzene derivatives: practical synthesis of fluoroaryl ethers and substituted resorcinols

In this Letter, we describe a practical and highly selective method for the preparation of fluoroaryl ethers and differentially substituted resorcinol derivatives. This synthetic strategy relies on a selective SNAr of substituted difluorobenzen

Regioselectivity of fluorine substitution by alkoxides on unsymmetrical difluoroarenes

An efficient approach to unsymmetrical halogenated resorcinol diethers has been developed. This synthesis consists of two subsequent nucleophilic aromatic substitutions (SNAr) of unsymmetrical difluoroarenes by alkoxides. The novelty of this ap